Handelsbanken Fonder AB Has $9.26 Million Stake in The Allstate Co. (NYSE:ALL)

→ Automatic Income (from home) (From Awesomely, LLC) (Ad)

Handelsbanken Fonder AB lowered its holdings in The Allstate Co. (NYSE:ALL - Free Report) by 28.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 66,138 shares of the insurance provider's stock after selling 26,382 shares during the period. Handelsbanken Fonder AB's holdings in Allstate were worth $9,258,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of ALL. Ellsworth Advisors LLC acquired a new stake in shares of Allstate in the 4th quarter valued at about $4,312,000. SteelPeak Wealth LLC lifted its holdings in Allstate by 175.2% during the 4th quarter. SteelPeak Wealth LLC now owns 15,682 shares of the insurance provider's stock worth $2,209,000 after buying an additional 9,984 shares during the last quarter. Assenagon Asset Management S.A. grew its position in shares of Allstate by 484.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 332,104 shares of the insurance provider's stock worth $46,488,000 after acquiring an additional 275,319 shares in the last quarter. Meeder Asset Management Inc. increased its holdings in shares of Allstate by 214.6% in the 4th quarter. Meeder Asset Management Inc. now owns 1,570 shares of the insurance provider's stock valued at $220,000 after acquiring an additional 1,071 shares during the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH raised its position in shares of Allstate by 88.7% during the 4th quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 24,496 shares of the insurance provider's stock valued at $3,429,000 after acquiring an additional 11,512 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.


Allstate Price Performance

Shares of ALL stock traded down $0.02 during mid-day trading on Thursday, hitting $172.25. 1,161,187 shares of the stock traded hands, compared to its average volume of 1,685,567. The Allstate Co. has a twelve month low of $100.57 and a twelve month high of $176.93. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.37 and a current ratio of 0.37. The company's 50-day simple moving average is $164.92 and its 200-day simple moving average is $148.75. The firm has a market cap of $45.31 billion, a price-to-earnings ratio of -138.91, a price-to-earnings-growth ratio of 0.43 and a beta of 0.52.

Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Thursday, February 8th. The insurance provider reported $5.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.87 by $1.95. The firm had revenue of $14.83 billion for the quarter, compared to analyst estimates of $12.69 billion. Allstate had a positive return on equity of 2.67% and a negative net margin of 0.33%. Allstate's revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.36) earnings per share. As a group, equities research analysts expect that The Allstate Co. will post 13.44 earnings per share for the current year.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Monday, March 4th were paid a dividend of $0.92 per share. The ex-dividend date was Friday, March 1st. This is a positive change from Allstate's previous quarterly dividend of $0.89. This represents a $3.68 annualized dividend and a dividend yield of 2.14%. Allstate's dividend payout ratio (DPR) is currently -296.77%.

Insider Transactions at Allstate

In other Allstate news, CAO John C. Pintozzi sold 4,000 shares of the company's stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the sale, the chief accounting officer now directly owns 10,736 shares of the company's stock, valued at $1,712,069.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, CAO John C. Pintozzi sold 4,000 shares of the company's stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the sale, the chief accounting officer now owns 10,736 shares in the company, valued at approximately $1,712,069.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider John E. Dugenske sold 31,000 shares of the business's stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the sale, the insider now directly owns 63,731 shares in the company, valued at $10,847,016.20. The disclosure for this sale can be found here. 1.80% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have weighed in on ALL. TD Cowen assumed coverage on shares of Allstate in a research note on Wednesday, January 10th. They set an "outperform" rating and a $193.00 target price for the company. The Goldman Sachs Group increased their price objective on shares of Allstate from $164.00 to $195.00 and gave the stock a "buy" rating in a research note on Monday, March 25th. UBS Group lifted their target price on Allstate from $171.00 to $185.00 and gave the company a "buy" rating in a research note on Monday, February 12th. JPMorgan Chase & Co. increased their price target on Allstate from $172.00 to $185.00 and gave the stock an "overweight" rating in a research report on Monday, April 8th. Finally, Morgan Stanley upped their price objective on Allstate from $187.00 to $190.00 and gave the stock an "overweight" rating in a research note on Monday, April 15th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $173.71.

Check Out Our Latest Stock Analysis on ALL

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

→ The asset beating inflation by 4x (From Colonial Metals) (Ad)

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

5 Hottest CEO Stock Purchases

5 Hottest CEO Stock Purchases

No insider is more significant than the CEO. This is a list of the five most significant CEO purchases in Q1 2024 based on dollar volume.

Search Headlines: